功能和尿导向性尿剂疗法 - 从PUSH-AHF试验中预先规定的分析
Kevin Damman1, Iris E Beldhuis1, Peter van der Meer1
1University of Groningen, Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
European journal of heart failure
|May 12, 2024
概括
导向性尿治疗对急性心力衰竭患者,包括功能受损患者有好处. 这种方法改善了结果,功能影响是暂时的,与较差的临床结果无关.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床试验 临床试验
背景情况:
- 急性心力衰竭 (HF) 的管理通常涉及利尿剂.
- 功能是HF预后和治疗反应的关键因素.
- 之前的研究表明,以自然尿素为导向的治疗改善了急性HF的尿路症.
研究的目的:
- 调查自然尿引导性利尿疗法对急性心力衰竭患者的影响,重点关注功能.
- 分析基线功能,恶化功能 (WRF) 和临床结果之间的关联.
- 为了比较 natriuresis引导疗法的疗效与不同程度的功能患者的标准护理.
主要方法:
- 在急性心力衰竭 (PUSH-AHF) 试验中对实用性尿基算法进行预先规定的分析.
- 患者被随机分配到以自然尿为导向的利尿剂治疗或标准护理.
- 在固定时间点评估血清肌素,估计的淋巴细胞过率 (eGFR) 和WRF.
主要成果:
- 基线eGFR并没有改变治疗对自然的效果.
- 较低的基线eGFR改变了对死亡率和HF再住院的治疗效果,在自然导小组中风险较低.
- 尿导向治疗导致eGFR的短暂下降,但WRF与更糟糕的结果无关.
结论:
- 在急性心力衰竭患者中, natriuresis引导的利尿治疗是有效的,无论基线eGFR或WRF.
- 该疗法即使在低EGFR患者中也显示出好处.
- 随着自然导疗法对eGFR的暂时变化与不良临床结果无关.
更多相关视频
相关概念视频
01:22Heart Failure Drugs: Diuretics
367
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
367
01:16Antihypertensive Drugs: Action of Diuretics
672
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
672
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
524
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
524
01:25Antihypertensive Drugs: Direct Renin Inhibitors
601
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
601
01:11Renal Failure: Dose Adjustments
85
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
85